Avita Medical Inc.
RCEL
Rank in Stocks
#12975
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic... AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Share Price
$17.12
Last synced: 2026-11-09
Market Cap
$425.31M
Change (1 day)
3.19%
Change (1 year)
332.32%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Avita Medical Inc. (RCEL)
Category
Healthcare
EPS for Avita Medical Inc. (RCEL)
EPS as of September 2026 TTM: $-1.19
According to Avita Medical Inc.'s latest financial reports, its current EPS (TTM) is $-1.19. At the end of 2025 the company had an EPS of $-1.74, an increase over its 2024 EPS of $-2.39.
EPS history for Avita Medical Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.19 | -31.61% |
| 2025 | $-1.74 | -27.20% |
| 2024 | $-2.39 | 70.71% |
| 2023 | $-1.40 | 30.84% |
| 2022 | $-1.07 | 3.88% |
| 2021 | $-1.03 | -50.24% |
| 2020 | $-2.07 | 84.21% |
| 2019 | $-1.12 | -39.31% |
| 2018 | $-1.85 | 6.87% |
| 2017 | $-1.73 | -15.73% |
| 2016 | $-2.06 | -8.86% |
| 2015 | $-2.26 | 42.36% |
| 2014 | $-1.58 | -40.41% |
| 2013 | $-2.66 | -17.40% |
| 2012 | $-3.22 | 183.25% |
| 2011 | $-1.14 | -71.20% |
| 2010 | $-3.95 | 4.00% |
| 2009 | $-3.79 | -76.99% |
| 2008 | $-16.49 | 408.38% |
| 2007 | $-3.24 | -6.07% |
| 2006 | $-3.45 | 1,791.18% |
| 2005 | $-0.18 | -94.10% |
| 2004 | $-3.10 | 52.57% |
| 2002 | $-2.03 | 293.58% |
| 2001 | $-0.52 | -33.26% |
| 2000 | $-0.77 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -326.89% |
US
|
|
| $4.09 | -443.70% |
IE
|
|
| $9.45 | -894.12% |
US
|
|
| $2.37 | -299.16% |
US
|
|
| $1.77 | -248.74% |
US
|
Questions about Avita Medical Inc.'s earnings per share (EPS)
What is Avita Medical Inc.'s earnings per share (EPS)?
Avita Medical Inc.'s earnings per share (EPS) over the last twelve months is $-1.19, as of Sep 2026.
What was Avita Medical Inc.'s earnings per share (EPS) in 2025?
In 2025, Avita Medical Inc.'s earnings per share (EPS) was $-1.74, compared with $-2.39 in 2024.
How has Avita Medical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Avita Medical Inc.'s earnings per share (EPS) was highest in 2021 ($-1.03) and lowest in 2024 ($-2.39).
How does Avita Medical Inc.'s earnings per share (EPS) compare with similar companies?
Avita Medical Inc.'s earnings per share (EPS) ($-1.19) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.